Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

NASDAQ Down Another 4% as Tech Selloff Continues

Published 09/08/2020, 09:15 PM
Updated 07/09/2023, 06:31 AM

SPECIAL ALERT: The September episode of the Zacks Ultimate Strategy Session will be available for viewing no later than Wednesday, September 16. Kevin Matras, Kevin Cook, Dan Laboe, Ben Rains and Sheraz Mian will cover the investment landscape from several angles in this popular event.

Don't miss your chance to hear:

• Ben and Dan Agree to Disagree on market valuation - is it still overvalued after this correction? Or because valuations are higher than they have been historically, but up against a different interest rate environment and recent tech-driven rally aspect, is it harder to compare?

• Kevin Matras answers your questions in Zacks Mailbag

• Sheraz and Dan choose one portfolio to give feedback for improvement

• And much more

Remember, we need your input. Please submit your questions for Zacks Mailbag and Portfolio Makeover by Thursday morning, September 10. Email now to mailbag@zacks.com.


The market was still in a selling mood coming back from the Labor Day weekend on Tuesday, and now the indices are on a three-day losing streak that has seen the NASDAQ plunge by more than 10%.

It’s only fitting that tech should lead us lower in this selloff, since the space was pushing everything higher in the great pandemic rebound that saw the indices skyrocket by more than 50% in five months.

Many market watchers, including most of our editors, have been waiting for something to ease the pressure… and it seems to finally be here.

The NASDAQ dropped another 4.11% (or about 465 points) on Tuesday to 10,847.69.

Of course, the FAANGs got beaten up with Apple (NASDAQ:AAPL) getting the worst of it by slumping 6.73%. The iPhone maker jumped 7% in the two days following its stock split, but that’s all gone now as it has plunged double-digits in this pullback.

The S&P was off 2.25% today to 3331.84, while the Dow had the ‘best’ performance with a slide of 2.25% (or about 632 points) to 27500.89. These indices are down approximately 7.1% and 5.6%, respectively, in the past three days.

The Dow had climbed within 450 points of a new high last Wednesday, but has since plunged about 1600 points.

The indices are coming back from a rare down week, which saw the NASDAQ drop 3.4% while the S&P and Dow slipped 2.4% and 1.9%, respectively. And now they have a down payment on another rough week as the toughest month for the stock market rolls on.

So how much more downside is to come? Given the runup of the past several months, more declines wouldn’t be out of the question.

However, investors are getting excited about the opportunity of buying some recently-overvalued names at much more attractive prices amid an amazing interest rate environment.


Today's Portfolio Highlights:

Counterstrike: This pullback is long overdue, according to Jeremy, and it has finally opened some buying opportunities on both the long and short sides. The editor added 5 names on Tuesday. The buys and their allocations were:

• Zebra Technologies (ZBRA) – 7%
• Lam Research (NASDAQ:LRCX) – 5%
• Advanced Auto Parts (AAP) – 5%
• Ultra Clean Energy (UCTT) – 5%
• Royal Caribbean (NYSE:RCL) – 5% (this is a short)

The first four additions all reported solid quarterly results, but have pulled back in this selloff. ZBRA, LRCX and UCTT tested their 200-day MAs, while AAP went down to its 50-day. LRCX, AAP and UCTT are Zacks Rank #1s (Strong Buys), while ZBRA is a Zacks Rank #2 (Buy). RCL is a Zacks Rank #5 (Strong Sell) that is being shorted on a purely technical basis, since Jeremy doesn’t think its problems are over.

Read the complete commentary for a lot more on each of these buys. By the way, the portfolio also sold Dollar Tree (NASDAQ:DLTR) and iRobot (NASDAQ:IRBT) after losing their solid Zacks Ranks amid weak price action.

Marijuana Innovators: The portfolio added a very small and highly-speculative investment on Tuesday. Artelo Biosciences (NASDAQ:ARTL) is a biotech company that’s doing research with receptors in the human endocannabinoid system for the treatment of many common conditions. Dave suggests that you “tread lightly” on this one, so make sure to read his complete commentary on ARTL.

Commodity Innovators: Lumber prices have been trending higher of late, so Jeremy wants some exposure to the space. And this pullback is giving him a great entry point. On Tuesday, the editor added Universal Forest Products (NASDAQ:UFPI), a Zacks Rank #2 (Buy) supplier of wood, wood composite and other products in the retail, industrial and construction markets. Meanwhile, it looks like the portfolio was really smart to change its mind and position for a downside move in crude. The ProShares UltraShort Bloomberg Crude Oil (SCO) position has surged 21.1% in just three days, so Jeremy decided to take this quick profit and move on. Read the full write-up for more on today’s action.

Zacks Short List: Half of the portfolio was changed this week. The positions that were short-covered included:

• Yandex N.V. (NASDAQ:YNDX, +7%)
• Marvell Technology (NASDAQ:MRVL, +4.1%)
• Netflix (NASDAQ:NFLX)
• V.F. Corp. (VFC)
• Nike (NYSE:NKE)

The new buys that replaced these names were:

• Burlington Stores (NYSE:BURL)
• China Lodging Group (HTHT)
• Five Below (NASDAQ:FIVE)
• Las Vegas Sands (NYSE:LVS)
• Ross Stores (NASDAQ:ROST)

Learn more about this emotion-free portfolio that takes advantage of falling and volatile markets by reading the Short List Trader Guide.

Black Box Trader: The portfolio replaced three positions in this week's adjustment, which is coming to you a day late due to the Labor Day holiday on Monday. The stocks that were sold today included:

• Hanesbrands (NYSE:HBI)
• Maxar Technologies (NYSE:MAXR)
• The Mosaic Co. (NYSE:MOS)

The new buys that filled these open positions were:

• At Home Group (NYSE:HOME)
• Big Lots (NYSE:BIG)
• Sportsmans Warehouse (SPWH)

Read the Black Box Trader’s Guide to learn more about this computer-driven service designed to take the emotion out of investing.

All the Best,
Jim Giaquinto

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Recommendations from Zacks' Private Portfolios:

Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>


Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.